ADIspell Inc. is a therapeutic research and development firm working toward successful treatments for drug overdose, poisoning, anxiety, and forms of dementia like Alzheimer’s Disease. The company has uncovered a new regulatory site on brain neuron proteins, and has identified the mechanism for how these neurons perform. With this discovery, the firm has restored cognitive performance to animal models with impaired memory and old age. They have also found a leading component that has shown success in treating drug overdose and poisoning.
ADispell Inc.'s technology is based on research completed in Cornell’s Department of Chemistry and Chemical Biology. The company often consults with faculty members in that department.